Avexitide for Treatment of Post-Bariatric Hypoglycemia
Trial details
- Registry ID
- NCT06747468
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as exendin 9-39
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Avexitide for Treatment of Post-Bariatric HypoglycemiaNCT06747468 | AMLX | Phase 3 | Active not recruiting | 2026-07-08Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |